| 176.31 0.01 (0.01%) | 11-11 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 228.12 | 1-year : | 245.29 |
| Resists | First : | 195.31 | Second : | 210 |
| Pivot price | 180.86  |
|||
| Supports | First : | 171.53 | Second : | 142.72 |
| MAs | MA(5) : | 177.02 |
MA(20) : | 180.59 |
| MA(100) : | 164.58 |
MA(250) : | 131.2 |
|
| MACD | MACD : | 0.2 |
Signal : | 1.4 |
| %K %D | K(14,3) : | 10.9 |
D(3) : | 11.2 |
| RSI | RSI(14): 45.4 |
|||
| 52-week | High : | 210 | Low : | 71 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ IRTC ] has closed above bottom band by 19.3%. Bollinger Bands are 28.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 182.93 - 183.8 | 183.8 - 184.59 |
| Low: | 172.86 - 173.86 | 173.86 - 174.78 |
| Close: | 174.67 - 176.31 | 176.31 - 177.79 |
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Mon, 10 Nov 2025
iRhythm Technologies, Inc. : Transforming Cardiac Diagnostics via AI - MarketScreener
Sun, 02 Nov 2025
US$220 - That's What Analysts Think iRhythm Technologies, Inc. (NASDAQ:IRTC) Is Worth After These Results - simplywall.st
Sat, 01 Nov 2025
iRhythm Technologies, Inc. (NASDAQ:IRTC) Q3 2025 Earnings Call Transcript - Insider Monkey
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 32 (M) |
| Shares Float | 32 (M) |
| Held by Insiders | 0.9 (%) |
| Held by Institutions | 115.9 (%) |
| Shares Short | 2,590 (K) |
| Shares Short P.Month | 2,660 (K) |
| EPS | -2.94 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.23 |
| Profit Margin | -14.1 % |
| Operating Margin | -5.8 % |
| Return on Assets (ttm) | -3.6 % |
| Return on Equity (ttm) | -91.2 % |
| Qtrly Rev. Growth | 26.1 % |
| Gross Profit (p.s.) | 14.27 |
| Sales Per Share | 20.45 |
| EBITDA (p.s.) | -1.48 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 63 (M) |
| Levered Free Cash Flow | 48 (M) |
| PE Ratio | -60.18 |
| PEG Ratio | 0 |
| Price to Book value | 54.58 |
| Price to Sales | 8.61 |
| Price to Cash Flow | 89.42 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|